Comment on: “Clinical Features, Management, and Prognosis of an International Series of 161 Patients With Limited-Stage Diffuse Large B-Cell Lymphoma of the Bone (the IELSG-14 Study)”

The conclusion of Ventre et al. is that patients with primary diffuse large B-cell lymphoma (DLBCL) of bone should be treated with anthracycline-based chemotherapy (the standard for all cases of DLBCL) with or without radiotherapy. The study suffers from several weaknesses that make the conclusion d...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Hoppe, Richard, Illidge, Tim, Specht, Lena, Vogelius, Ivan, Yahalom, Joachim
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2014
Assuntos:
Letters to the Editor
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4257744/
https://ncbi.nlm.nih.gov/pubmed/25480339
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2014-0200
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados